{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:05:52Z","timestamp":1793160352590,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jtct.2025.12.952","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:39:47Z","timestamp":1765669187000},"page":"487.e1-487.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-World Effectiveness of Recombinant Zoster Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1168-3666","authenticated-orcid":false,"given":"Raeseok","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dukhee","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Yeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daehun","family":"Kwag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Je","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Sik","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9810-2050","authenticated-orcid":false,"given":"Sung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-0641","authenticated-orcid":false,"given":"Dong-Gun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2025.12.952_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2022.11.005","volume":"86","author":"Miller","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.jtct.2025.12.952_bib0002","first-page":"3496","article-title":"Towards personalized prevention of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an <I>ad hoc<\/I>Italian expert panel","volume":"109","author":"Girmenia","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2025.12.952_bib0003","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/cid\/ciaa222","article-title":"High incidence of herpes zoster after cord blood hematopoietic cell transplant despite longer duration of antiviral prophylaxis","volume":"72","author":"Xue","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2025.12.952_bib0004","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1093\/cid\/ciz1090","article-title":"Herpes zoster risk in immunocompromised adults in the United States: a systematic review","volume":"71","author":"McKay","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2025.12.952_bib0005","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation\u2014a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.12.952_bib0006","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3904\/kjim.2018.036","article-title":"Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea","volume":"33","author":"Cho","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jtct.2025.12.952_bib0007","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41409-019-0717-8","article-title":"Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation","volume":"55","author":"Mascarenhas","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.12.952_bib0008","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2025.12.952_bib0009","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S1473-3099(19)30163-X","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis","volume":"19","author":"Dagnew","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jtct.2025.12.952_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vaccine.2022.10.063","article-title":"Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions","volume":"41","author":"Sullivan","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jtct.2025.12.952_bib0011","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial","volume":"322","author":"Bastidas","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2025.12.952_bib0012","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3947\/ic.2023.0072","article-title":"Recommendations for adult immunization by the Korean Society of Infectious Diseases, 2023: minor revisions to the 3rd edition","volume":"56","author":"Choi","year":"2024","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jtct.2025.12.952_bib0013","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/bloodadvances.2020003749","article-title":"Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation","volume":"5","author":"Baumrin","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.12.952_bib0014","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/vaccines10050809","article-title":"Cellular immune response after vaccination with an adjuvanted, recombinant zoster vaccine in allogeneic hematopoietic stem cell transplant recipients","volume":"10","author":"Koldehoff","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.jtct.2025.12.952_bib0015","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1016\/j.vaccine.2021.04.052","article-title":"Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation\u2014a single center retrospective efficacy analysis","volume":"39","author":"Sattler","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jtct.2025.12.952_bib0016","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.3390\/cancers13236140","article-title":"Vaccine responses in adult hematopoietic stem cell transplant recipients: a comprehensive review","volume":"13","author":"Janssen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtct.2025.12.952_bib0017","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2008.386","article-title":"Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia","volume":"43","author":"Styczynski","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.12.952_bib0018","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5021\/ad.2018.30.2.253","article-title":"Validation of herpes zoster diagnosis code in the electronic medical record: a retrospective, multicenter study","volume":"30","author":"Kim","year":"2018","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jtct.2025.12.952_bib0019","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.12.952_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.12.952_bib0021","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.12.952_bib0022","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022","volume":"71","author":"Anderson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jtct.2025.12.952_bib0023","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbmt.2019.11.008","article-title":"Allogeneic haploidentical blood or marrow transplantation with post-transplantation cyclophosphamide in chronic lymphocytic leukemia","volume":"26","author":"Paul","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.12.952_bib0024","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1080\/21645515.2021.1953346","article-title":"Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice","volume":"17","author":"Stadtmauer","year":"2021","journal-title":"Human Vaccin Immunother"},{"key":"10.1016\/j.jtct.2025.12.952_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2023.100397","article-title":"Efficacy and safety of the recombinant zoster vaccine: a systematic review and meta-analysis","volume":"15","author":"Zeevaert","year":"2023","journal-title":"Vaccine X"},{"key":"10.1016\/j.jtct.2025.12.952_bib0026","article-title":"VZV prophylaxis after allogeneic hematopoietic stem cell transplantation in children: when to stop?","volume":"7","author":"de Berranger","year":"2024","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.jtct.2025.12.952_bib0027","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ard.2025.01.045","article-title":"Effectiveness and safety of the recombinant zoster vaccine in individuals \u226550 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study","volume":"84","author":"Rayens","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2025.12.952_bib0028","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.ophtha.2021.04.017","article-title":"Effectiveness of the recombinant zoster vaccine for herpes zoster ophthalmicus in the United States","volume":"128","author":"Lu","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtct.2025.12.952_bib0029","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cid\/ciz177","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial","volume":"70","author":"Vink","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2025.12.952_bib0030","article-title":"Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance","volume":"9","author":"Fiore","year":"2021","journal-title":"Ther Adv Vaccines Immunother"},{"key":"10.1016\/j.jtct.2025.12.952_bib0031","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jamaophthalmol.2023.6830","article-title":"Risk of herpes zoster ophthalmicus recurrence after recombinant zoster vaccination","volume":"142","author":"Walia","year":"2024","journal-title":"JAMA Ophthalmol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725026120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725026120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T19:31:32Z","timestamp":1778355092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725026120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666636725026120"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.952","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Effectiveness of Recombinant Zoster Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}